...
首页> 外文期刊>Surgery >Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia.
【24h】

Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia.

机译:微创食管切除术用于高度不典型增生的Barrett食管。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Barrett's esophagus with high-grade dysplasia (BE/HGD) is associated with invasive carcinoma in 30% to 70% of cases. Esophagectomy is the treatment of choice for patients with BE/HGD but esophagectomy can be associated with high morbidity and mortality. The aim of our study was to report our preliminary experience in applying minimally invasive surgical techniques to esophagectomy for BE/HGD. METHODS: From August 1996 to February 1999, 12 consecutive patients underwent minimally invasive esophagectomy for biopsy-proven BE/HGD. Our consort consisted of 7 men and 5 women; average age was 64 years (range, 40-78 years). All patients underwent a complete laparoscopic or combined laparoscopic and thoracoscopic resection of the esophagus with cervical anastomosis. RESULTS: Mean operative time was 7.8 +/- 2.1 hours, mean intensive care unit stay was 2.6 +/- 2.2 days, and mean length of hospital stay was 8.3 +/- 4.7 days. Five patients (42%) had carcinoma in situ or carcinoma identified on pathologic specimen. Analyses of all resected lymph nodes in the 12 patients were negative for metastatic disease. There were 6 major complications in 5 patients: 1 patient had a small bowel perforation requiring operative repair, 2 patients needed prolonged ventilatory support for respiratory insufficiency, and 3 patients had delayed gastric emptying requiring revision of the pyloromyotomy. The single minor complication in this series was a jejunostomy tube-site infection. There were no conversions to laparotomy or thoracotomy. All patients were alive and free of metastatic disease at a mean follow-up of 12.6 months. CONCLUSIONS: Minimally invasive esophagectomy is a feasible and safe alternative to conventional open esophagectomy for patients with BE/HGD.
机译:背景:具有高度不典型增生(BE / HGD)的巴雷特食管在30%至70%的病例中与浸润性癌相关。食管切除术是BE / HGD患者的首选治疗方法,但食管切除术可能会导致较高的发病率和死亡率。我们研究的目的是报告我们在将微创外科技术应用于食管切除术进行BE / HGD方面的初步经验。方法:从1996年8月至1999年2月,连续12例患者接受了经活检证实的BE / HGD微创食管切除术。我们的同伴包括7名男性和5名女性;平均年龄为64岁(范围为40-78岁)。所有患者均接受了完整的腹腔镜或联合腹腔镜和胸腔镜食管切除术并进行了宫颈吻合术。结果:平均手术时间为7.8 +/- 2.1小时,平均重症监护病房住院时间为2.6 +/- 2.2天,平均住院时间为8.3 +/- 4.7天。五名患者(42%)患有原位癌或在病理标本上发现癌。 12例患者中所有切除的淋巴结的分析均为转移性疾病阴性。 5例患者中有6例主要并发症:1例患者肠穿孔小,需要手术修复; 2例患者呼吸功能不全需要长期通气支持; 3例胃排空延迟,需进行幽门切开术。该系列中的单个较小并发症是空肠造口管部位感染。没有转换为开腹手术或开胸手术。所有患者均存活且无转移性疾病,平均随访12.6个月。结论:对于BE / HGD患者,微创食管切除术是常规开放式食管切除术的一种可行且安全的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号